CONTACTS 

SUBJECTS
Treatment Cetuximab 2nd Treatment 3rd Cycle Chemotherapy 10th Cycle

1103 -
1103 -    ..
1104 - Summary/Objective
1105 -
110501 - Follow up ref SDS 34 0000. ref SDS 30 0000.
110502 -
110503 - Treatment at O830 in the Infusion Clinic. ref SDS 0 1M6H  There was no
110504 - meeting in the Breast Care Center today because examinations occur
110505 - every other treatment, and today is the 2nd treatment of the cycle.
110506 - Treatment Brigid prescribed reducing the dose of Benadryl has been
110507 - successful elminating side effects of "restless legs. ref SDS 0 F77K
110508 - Difficulty sleeping has also disappated with increasing good news of
110509 - effective treatment. ref SDS 0 NG3I  Energy continues to increase.
110510 - ref SDS 0 CA4K  Millie took a nap for a few hours after getting home
110511 - from treatment today. ref SDS 0 BB7G
110512 -
110513 -
110514 -
110515 -
110517 -  ..
1106 -
1107 -
1108 - Progress
1109 -
110901 - Clinic Examination Orientation Starting Treatment Cetuximab
110902 -
110903 - Follow up ref SDS 34 407N, ref SDS 30 407N.
110905 -  ..
110906 - Agenda...
110907 -
110908 -    1.  Infusion Clinic........................... ref SDS 0 1M6H
110909 -    2.  Side effects.............................. ref SDS 0 QU8K
110910 -
110911 -
110912 -
110913 -
1110 -

SUBJECTS
Breast Examination Not Performed in Breast Care Clinic Prior to Trea

1903 -
190401 -  ..
190402 - Breast Examination Likely IBC 2 Scenarios Spreading Intensity Declines
190403 -
190404 - Follow up ref SDS 34 FO6H, ref SDS 30 FO6H.
190405 -
190406 - There was no examination today.
190407 -
190408 -
190409 -
1905 -

SUBJECTS
Emotional Health Not Reviewed Examination Breast Care Clinic Prior t

2503 -
250401 -  ..
250402 - Emotional Roller Coaster Endemic Cancer Treatment and Coordination
250403 -
250404 - Follow up ref SDS 34 6A7J, ref SDS 30 6A7J.
250405 -
250406 - There was no examination today.
250407 -
250408 -
2505 -

SUBJECTS
Prognosis Reviewed During Examination Breast Care Clinic Prior to Tr

3003 -
300401 -  ..
300402 - Cetuximab Prognosis IBC May Subside for 10 Months Before Progressing
300403 - Prognosis Disease May Subside 10 Months or More Before Progression
300404 - Progresssion of Disease May be Delayed for 10 Months or More
300405 -
300406 - Follow up ref SDS 34 6A9H, ref SDS 30 6A9H.
300407 -
300408 - There was no examination today.
300409 -
300410 -
300411 -
300412 -
3005 -

SUBJECTS
Measurable Disease Not Reviewed No Examination Breast Care Clinic Pr

3503 -
350401 -  ..
350402 - Measureable Disease Photographs IBC Rash Improving
350403 - IBC Rash Improved Measurable Disease Photographs Tape Measure
350404 -
350405 - Follow up ref SDS 34 6T6M, ref SDS 30 6T6M.
350406 -
350407 - There was no examination today.
350408 -
350409 -
350410 -
350411 -
3505 -

SUBJECTS
Side Effects Not Reviewed No Examination Breast Care Clinic Prior to

4003 -
400401 -  ..
400402 - Side Effects Medicated After Weekly Examinations
400403 -
400404 - Follow up ref SDS 34 FO66, ref SDS 30 FO66.
400405 -
400406 - There was no examination today.
400407 -
400408 -
400409 -
4005 -

SUBJECTS
Cetuximab 3rd Cycle 2nd Treatment 10th Total Treatment Chemotherapy

4603 -
4604 - 0830
460501 -  ..
460502 - Infusion Clinic for Cetuximab Treatent
460503 -
460504 - Follow up ref SDS 34 1M6H, ref SDS 30 1M6H.
460505 -
460506 - Millie received 10th overall and 2nd treatment of 3rd cycle with
460507 - Cetuximab, starting from 070201, ref SDS 15 G68I, and the 17th
460508 - treatment for 3rd relapse of IBC, beginning on 060721. ref SDS 4 407N
460510 -  ..
460511 - Catherine was the nurse today.
460513 -           ..
460514 -          Taxotere Capecitabine
460515 -
460516 -          Follow up ref SDS 34 PR8Q, ref SDS 30 PR8Q.
460517 -
460518 -                   Relapse Treatments
460519 -
460520 -      1.  Cycle 09 and 01 ................... 060721, ref SDS 4 407N
460521 -      2.  Cycle 10 and 02 ................... 060814, ref SDS 7 LY6O
460522 -      3.  Cycle 11 and 03 ................... 060908, ref SDS 8 407N
460523 -      4.  Cycle 12 and 04 ................... 060929, ref SDS 9 407N
460524 -      5.  Cycle 13 and 05 ................... 061020, ref SDS 10 407N
460525 -      6.  Cycle 14 and 06 ................... 061110, ref SDS 11 407N
460526 -      7.  Cycle 15 and 07 ................... 061201, ref SDS 12 407N
460528 -           ..
460529 -          Cetuxiab Clinical Study
460530 -
460531 -          Follow up ref SDS 34 7T3H, ref SDS 30 7T3H.
460532 -
460533 -                   Total    Cetuximab
460534 -      8.  Cycle 01 and 08 and 01 01.......... 070201, ref SDS 15 SG8I
460535 -      9.  Cycle 01 and 08 and 02 02.......... 070208, ref SDS 17 SG8I
460536 -     10.  Cycle 01 and 08 and 03 03.......... 070215, ref SDS 18 SG8I
460537 -     11.  Cycle 01 and 08 and 04 04.......... 070222, ref SDS 21 7T3H
460538 -     12.  Cycle 02 and 09 and 01 05.......... 070301, ref SDS 24 7T3H
460539 -     13.  Cycle 02 and 09 and 02 06.......... 070308, ref SDS 27 7T3H
460540 -     14.  Cycle 02 and 09 and 03 07.......... 070315, ref SDS 29 7T3H
460541 -     15.  Cycle 02 and 09 and 04 08.......... 070322, ref SDS 30 7T3H
460542 -     16.  Cycle 03 and 10 and 01 09.......... 070329, ref SDS 34 7T3H
460543 -     17.  Cycle 03 and 10 and 02 10.......... 070405, ref SDS 0 7T3H
460545 -  ..
460546 - Nurses Notes...
460557 -  ..
460558 - Why is the visit number constant in Nurse's Notes, and yet seems to
460559 - vary in the schedule received from Nola last week? ref SDS 29 159O
460561 -     ..
460562 -    UCSF Log Time...
460563 -
460564 -                   Blood
460565 -                    Test   Infusion
460566 -
460567 -          In.......          0830
460568 -          Out......          1130
460569 -          Visit....      Min  2.5  Hours  Total 3 Hours
460571 -      ..
460572 -     Pain Assessment...
460573 -
460574 -          x
460575 -          0123456789 10
460576 -
460577 -     <923k
460578 -     Administration Site:  Right Port Catheter
460579 -     Needle Size:          20 G 1"
460580 -     Blood Return Good:    Yes
460582 -      ..
460583 -     Remind patient to call MD if temp > 101 F, Shaking Chills
460584 -
460585 -            This protocol differs from Kaiser requirements, reported on
460586 -            041202. ref SDS 1 IX9N
460587 -
460588 -
460589 -
460590 -
4606 -

SUBJECTS
Side Effects Infusion Clinic UCSF Consultation Treatment Cetuximab A

5903 -
5904 - 0840
590501 -  ..
590502 - Side Effects Minimal...
590503 -
590504 - Follow up ref SDS 34 QU8K, ref SDS 30 QU8K.
590506 -  ..
590507 - Nurse's notes report side effects...
590508 -
590509 -        1.  Rash acne-like...... ref SDS 34 SK9O
590510 -
590511 -               Minimal facial rash continues from 070208 around the
590512 -               nose and chin, ref SDS 17 QU8K; treatment effective with
590513 -               medication prescribed on 070222. ref SDS 21 FO66
590515 -             ..
590516 -        2.  Dry skin face, chest arm...... ref SDS 34 JS6M
590517 -
590518 -               Background on notice and treatments prescribed reported
590519 -               on 070322. ref SDS 30 JS6M  Medical team commented
590520 -               during examination on 070329, how well Millie looks.
590521 -               ref SDS 33 N49K  The next day on 070330, the primary
590522 -               care physician at Kaiser commented similarly, during
590523 -               follow up examination. ref SDS 36 N49K  This indicates
590524 -               UCSF examinations by Catherine in the Infusion Clinic,
590525 -               and by Brigid in the Breast Care Center has been timely,
590526 -               thorough, and effective prescribing Curel on 070301,
590527 -               ref SDS 23 5V73, and later Aquaphor on 070322.
590528 -               ref SDS 30 JS6M
590530 -             ..
590531 -        3.  Rash on right chest....... ref SDS 34 KU3L
590532 -
590533 -               Examination of right chest observes various blemishes.
590534 -               Nurses's Notes today say no rash noted above the port,
590535 -               continuing observations the last several weeks reported
590536 -               on 070329. ref SDS 34 KU3L  On 070330 examination at
590537 -               Kaiser showed significantly increased intensity of rash
590538 -               on upper left arm, ref SDS 36 N19J, and a similar new
590539 -               rash above the right breast and below the colar bone.
590540 -               ref SDS 36 583G  Rash on the upper right chest was
590541 -               previously reported in Nurse's Notes on 070315 during
590542 -               treatment at UCSF. ref SDS 29 KU3L  Kaiser diagnosed
590543 -               Cellulitis possibly complications of lymphedema, citing
590544 -               elevated temperature, and possibly triggered by
590545 -               patient's increased exercise that overtaxed the system.
590546 -               ref SDS 36 7C7F  Keflex antibiotics was prescribed,
590547 -               ref SDS 36 474O; about 3 hours later self-examination
590548 -               showed these erruptive rash conditions had subsided, and
590549 -               so Keflex treatment was not performed. ref SDS 36 KZ6L
590550 -               Examination today finding no evidence of rash on the
590551 -               upper right chest and below the collar bone aligns with
590552 -               patient history of erratic rash, rather than advancing
590553 -               IBC. ref SDS 14 5N6L
590555 -             ..
590556 -        4.  Rash right arm............... ref SDS 34 LI4M
590557 -
590558 -               Catherine does not comment on this issue in Nurse's
590559 -               Notes today.  Examination by the medical team on 070329
590560 -               found no evidence of disease in the right arm.
590561 -               ref SDS 33 H15M
590563 -             ..
590564 -        5.  Restless legs side effect Benedryl...... ref SDS 34 F77K
590565 -
590566 -               This was resolved on 070329 by Brigid changing the
590567 -               chemotherapy order to reduce the dose of Benadryl
590568 -               pre-treatment. ref SDS 33 MF4N
590570 -             ..
590571 -        6.  Sleeping difficulty................. ref SDS 34 NG3I
590572 -
590573 -               This problem has subsided as worry and doubt have been
590574 -               reduced by continuing favorable reports showing response
590575 -               to treatment, discussed with the medical team during
590576 -               examination on 070329. ref SDS 33 Y642
590577 -
590579 -             ..
590580 -        7.  Lymphedema Cellulitis Complications...... ref SDS 34 SU6L
590581 -
590582 -               Lymphedema continues relatively controlled with major
590583 -               swelling in the left arm, measured this morning before
590584 -               treatment 11.25, and shown by the study on 060509.
590585 -               ref SDS 2 HO7F  There is no evident association with
590586 -               cetuximab treatments.  Proximate cause was left breast
590587 -               mastectomy with removal of lymph nodes in the left
590588 -               axillary, complicated by exercise to strengthen the
590589 -               immune system for resisting cancer, and by cat bites
590590 -               that flow from engaging pets for qualify of life,
590591 -               reported in the case study on 070130. ref SDS 14 VX6F
590593 -                ..
590594 -               Increased intensity of rash on the upper left arm was
590595 -               reported on 070330 during examination at Kaiser by
590596 -               primary care physician. ref SDS 36 N19J   This was bone,
590597 -               ref SDS 36 583G; these dramatic changes in diagnosed
590598 -               without biopsy as complications of lymphedema causing
590599 -               Cellulitis with elevated temperature, and possibly
590600 -               triggered by patient's increased exercise that overtaxed
590601 -               the system. ref SDS 36 7C7F  Keflex antibiotics was
590602 -               prescribed, ref SDS 36 474O; about 3 hours later
590603 -               self-examination showed these erruptive rash conditions
590604 -               had subsided, and so Keflex treatment was not performed.
590605 -               ref SDS 36 KZ6L   Today, there is no evidence of
590606 -               increased rash intensity of the upper left arm.
590607 -
590609 -             ..
590610 -        8.  Tired, fatigued - pulmonary emoblism... ref SDS 34 FG3N
590611 -
590612 -               Fatigue, shortness of breath and other symptoms of
590613 -               pulmonary embolism were presented during meeting on
590614 -               070130, ref SDS 14 CV5L, citing case study listed on
590615 -               060722. ref SDS 5 ZV41
590617 -                ..
590618 -               Energy that seemed to be declining leading up to
590619 -               treatment on 070301, ref SDS 24 CA4K, has continued to
590620 -               rise back to normal, as reported last week on 070322.
590621 -               ref SDS 30 CA4K  Millie continues working out in the
590622 -               gym, and has started hiking the trail at Lafayette
590623 -               Reservoir again, as reported to the medical team during
590624 -               examination on 070329. ref SDS 33 E44L  Increased
590625 -               exercise in the morning on 070330 may have triggered
590626 -               symptoms of Cellulitis diagnosed during examination
590627 -               later in the afternoon on 070330. ref SDS 36 7C7F
590629 -             ..
590630 -        9.  Heavy chest - shortness of breathing..... ref SDS 34 UL6L
590631 -
590632 -               Patient history was reported to UCSF on 070130.
590633 -               ref SDS 14 RT6I
590634 -
590635 -               Condition seems improved, tracking continuing higher
590636 -               energy, per above. ref SDS 0 CA4K
590637 -
590639 -             ..
590640 -       10.  Cough - clearing throat............... ref SDS 34 8N4G
590641 -
590642 -               This condition occassionally increases noticably with
590643 -               episodes of mild, contined cough and clearing throat, as
590644 -               reported to the doctor on 070130. ref SDS 14 RT6I
590645 -
590647 -             ..
590648 -       11.  Dry hands and feet................ ref SDS 34 UM32
590649 -
590650 -               Dry hands and feet seem much improved since ending
590651 -               treatment with Taxotere and capecitiabine on 061201.
590652 -
590654 -             ..
590655 -       12.  Eyes tearing...................... ref SDS 34 HM9G
590656 -
590657 -               This seems improved since ending treatment with Taxoter
590658 -               and capecitabine on 061201.
590659 -
590661 -             ..
590662 -       13.  Nausea and vomitting................. ref SDS 34 D19M
590663 -
590664 -               Problems with Taxotere and capecitabine reported on
590665 -               061110, ref SDS 11 D19M, did not occur this past week
590666 -               after treatment with cetuximab.  As a result, there was
590667 -               no pre-treatment with Decadron today, per below.
590668 -               ref SDS 30 G57I
590670 -             ..
590671 -       14.  Sores in mouth................... ref SDS 34 KW4R
590672 -
590673 -               None yet, cleaning mouth carefully to avoid problem.
590674 -
590675 -
590676 -
590677 -
5907 -

SUBJECTS
Schedule Treatment Weekly Thursday 0800 4 Week Cycles Clinical Study

6503 -
650401 -  ..
650402 - Schedule Weekly Treatments Continue on Thursdays
650403 -
650404 - Follow up ref SDS 34 QK6L, ref SDS 30 QK6L.
650406 -  ..
650407 - Millie's next treatment is scheduled for 070412 0800, reported by Nola
650408 - on 070315. ref SDS 29 159O
650409 -
650410 -
650411 -
650412 -
6505 -

SUBJECTS
Port Catheter IV Connection Prepare for Drip Treatment 1 Try Require

7203 -
7204 - 0850
720501 -  ..
720502 - Preparation for Treatment Required One (1) Attempt to Connect Port
720503 -
720504 - Follow up ref SDS 34 EB7J, ref SDS 30 EB7J.
720506 -  ..
720507 - The nurse connected the IV tubes to the port....
720509 -       ..
720510 -      Interlink System Vented Paclitaxel set
720512 -  ..
720513 - Like last week and earlier on 070301, there were no problems getting
720514 - blood to flow from the port, ref SDS 24 EB7J, as occurred on 070222,
720515 - ref SDS 20 DC5W, and earlier on 070201. ref SDS 15 DC5W
720517 -  ..
720518 - The nurse flushed the port with saline.
720519 -
720520 -
720521 -
720522 -
7206 -

SUBJECTS
Blood Draws None Today 7 Vials Clinical Study Research Cetuximab Dru

7903 -
790401 -  ..
790402 - Blood Draws 7 Vials for Clinical Study Research
790403 -
790404 - Follow up ref SDS 34 O56V, ref SDS 30 O56V.
790405 -
790406 - Blood draws for the clinical study occur only to start a new cycle; so
790407 - there were no blood draws today during the 2nd treatment of cycle 3.
790408 -
790409 -
790410 -
790411 -
790412 -
7905 -

SUBJECTS
Benadryl Pre-treatment Prepares Patient for Cetuximab Chemotherapy A

8503 -
8504 - 0900
850501 -  ..
850502 - Benadryl Reduce Side Effects Cetuximab Chemotherapy Treatment
850503 -
850504 - Follow up ref SDS 34 DC7J, ref SDS 30 DC7J.
850505 -
850506 - Benadryl (diphenhydramine) started.   50 MG....... ref SDS 30 IJ41
850507 -
850508 -        Purpose reported on 060721. ref SDS 4 DC7J
850510 -  ..
850511 - Chemotherpay order calls for Benadryl (diphenhydramine) pre-treatment
850512 - 30 - 60 minutes prior to cetuximab infusion, shown below. ref SDS 0
850513 - IJ41
850514 -
850516 -  ..
8506 -
8507 -
8508 - 0915
8509 -
850901 - Benedryl completed equipment beeps.
850903 -  ..
850904 - Millie reported that decreasing the dose of Benadryl pre-treatment to
850905 - 25 mg completely eliminated previous problems of "restless legs," per
850906 - above. ref SDS 34 F77K
850907 -
850908 -
850910 -  ..
8510 -
8511 -
8512 -
8513 -
851301 - Decadron (dexamethasone) IV pre-treatment........ ref SDS 30 FM4M
851302 -
851303 - On 070208 Decadron was not given because Millie did not experience
851304 - side effects of nausea and vomitting after treatment with cetuximab on
851305 - 070201. ref SDS 17 G57I  Since this favorable condition continues, per
851306 - above, ref SDS 30 D19M, Decadron was not given again today.
851307 -
851309 -  ..
8514 -
8515 -
8516 -
851601 - Decadron completed -- not reported.
851602 -
851603 -
851604 -
851605 -
8517 -

SUBJECTS
Cetuximab 3rd Cycle 2nd Treatment Clinical Study Drug Trial Treatmen

9403 -
9404 - 0920
940501 -  ..
940502 - Cetuximab Full Dose Blood Counts on Targets Treatment 1 Hour
940503 -
940504 - Follow up ref SDS 34 4N5M, ref SDS 30 4N5M.
940506 -  ..
940507 - Cetuximab started.
940508 -
940509 -           Verify chemotherapy order for 070208.
940511 -  ..
940512 - Chemotherapy order calls for cetuximab to start 30 - 60 minutes after
940513 - Beyadryl pre-tretment. ref SDS 30 IJ41
940515 -  ..
940516 - Chemotherapy Orders...
940517 -
940523 -    Auth#                                     Stor BCC LOC
940524 -    Visit:  12575738             DOS 20070201
940526 -     ..
940527 -    Date:  20070201
940529 -     ..
940530 -    Study Order for CC#05752:  Phase II Trial of Cetuximab alone and
940531 -    in combination with Carboplatin in ER-negative, PR-negative,
940532 -    HER2-negative Nonoverexpressing Metastatic Breast Cancers
940534 -     ..
940535 -    Dates to be given:  070201
940536 -    Arm 1:Cetuximab alone
940538 -     ..
940539 -    Diagnosis:  breast cancer
940541 -     ..
940542 -    ICD-9 codes: 174.9
940543 -    Allergies  NKDA
940545 -     ..
940546 -    Pre-medications 30 - 60 minutes prior to cetuximab infusion
940548 -     ..
940549 -    3. Diphenhydramine 25 mg IV or  [illegible writing]
940550 -
940551 -       Benadryl........... ref SDS 30 DC7J
940552 -
940553 -       Earlier this morning, Brigid changed the Chemotherapy Order
940554 -       reducing Diphenhydramine (Benadryl) from 50 mg to 25 mg in order
940555 -       to reduce side effects of "restless legs," per above.
940556 -       ref SDS 34 F77K
940558 -        ..
940559 -       This was effective, reported above. ref SDS 34 7R6H
940561 -     ..
940562 -    4. Dexamethasone (??) 10 mg IB or 20 mg IV [handwritten ???]
940563 -
940564 -       Further premed TBD [barely legible handwriting??]
940566 -     ..
940567 -    Medication:  (plan to give weekly ********STUDY SUPPLY**********
940569 -     ..
940570 -    5. Cetuximab (Erbitux) (loading dose)
940571 -
940572 -              400 mg/m [squared] = 684 mg IV over 120 minutes for
940573 -              first dose x 1
940574 -
940575 -       dose on dcte 20070201   Maximum infusion rate is 5 ml/minute
940576 -       (concentration 2 mg/ml)
940578 -     ..
940579 -    6. Cetuximab (Erbitux) (maintenance dose)
940580 -
940581 -              250 mg/m [squared] = 428 mg IV (or ____ mg/m[squared] =
940582 -              ____mg) IV over 60 or ____ minutes.
940583 -
940584 -       Maximum infusion rate is 5 ml/minute (concentration 2 mg/ml)
940585 -       Infuse once weekly for 8 weeks.  First dose to be given on date
940586 -       20070201.
940588 -        ..
940589 -       Cetuximab is administered undiluted through a low protien
940590 -       binding 0.22 micro in-line filter.  Use NS solution to flush the
940591 -       line at the end of the infusion.
940593 -        ..
940594 -       ARM 2:  Administer carboplatin of vital signs are unremarkable
940595 -       one hour after cetuximab infusion.
940597 -        ..
940598 -       Vital signs at baseline, upon cetuximab completion and one hour
940599 -       after cetuximab.
940600 -
940601 -       ****please note start and stop times****
940603 -        ..
940604 -       Laboratory work:
940605 -
940606 -          See carboplatin orders
940608 -        ..
940609 -       x  Notify MD for dose modifications if patient has severe
940610 -          acne in form rash
940611 -
940612 -          CBC with differential and platletes every 4 weeks
940613 -          Creatinine and magnesium every 4 weeks
940614 -          BUN AST Alk phos Alt Total bilrubin, electrolyes every 8
940615 -          weeks.  If levels are outside of normal laboratory values
940616 -          notify Brigid NP  (MD/RN) at 415 443 4730
940618 -        ..
940619 -       x  Physician has discussed risks/benefits of therapy with the
940620 -          patient.  Signed consent obtained.
940621 -
940622 -
940623 -          Yes  No   O2 by nasal cannula at 2 liters/min prn for chest
940624 -          pain or SOB
940626 -           ..
940627 -          Yes  No   Diphenhydramine 50 mg IV prn x1 for urticaria
940628 -          [barely legible], pruritis SOB
940630 -           ..
940631 -          Yes  No   Hydrocortizone 100 mg IV prn x1 for urticaria
940632 -          [barely legible], pruritis SOB
940634 -           ..
940635 -          Yes  No   Albuterol inhaler 2-4 puffs prn SOB or chest
940636 -          tightness
940638 -           ..
940639 -          Yes  No   Epinephrine 1x1000 (1 mg/ml) 0.3 mg IV prn
940640 -          anaphylaxis
940642 -           ..
940643 -          Breast CC05752 Cetuximab doc 20061024
940644 -          Approved 20060615
940646 -           ..
940647 -          Physician signature [Hope Rugo]
940649 -           ..
940650 -          Provider#  35313
940652 -           ..
940653 -          Date:  20010131
940654 -
940656 -  ..
9407 -
9408 -
9409 - 1020
9410 -
941001 - Cetuximab treatment completed.
941002 -
941003 - Millie had a 1 hour rest and observation period, required by the
941004 - protocol. ref SDS 30 G679
941005 -
941006 -
941007 -
941009 -  ..
9411 -
9412 -
9413 - 1130
9414 -
941401 - Diane disconnected the IV tubes.
941403 -  ..
941404 - She inserted Herceptin to flush the port.
941406 -  ..
941407 - She then removed the needle from the port, and swabbed the needle
941408 - wound, and placed a temporary bandage.
941409 -
941410 -
941411 -
941412 -
941413 -
9415 -

SUBJECTS
Vitals Blood Pressure Pulse Temperature Sa02 Weight Infusion Treatme

A103 -
A104 - 0900
A10501 -  ..
A10502 - Vitals Show Patient Stable
A10503 -
A10504 - Follow up ref SDS 34 AW4L, ref SDS 30 AW4L.
A10505 -
A10506 -                    Blood
A10507 -    Date   Time     Pressure   Pulse  Temprtr  Weight   So2
A10508 -
A10509 -        [On 070329 followed up. ref SDS 33 XU6M
A10511 -     ..
A10512 -    070405 1130..... 133  75     55     36.2c            97
A10513 -    070405 1030..... 114  69     57     36.4c            99
A10514 -    070405 0900..... 128  78     54     36.5c           100
A10515 -    070329 1140..... 125  74     53     36.8c            98
A10516 -    070329 1045..... 125  72     53         c           100
A10517 -    070329 0900..... 141  76     60     36.6c            99
A10518 -    070322 1055..... 118  71     55     37.0c            97
A10519 -    070322 1015..... 120  69     57     37.1c            98
A10520 -    070322 0900..... 130  70     56     36.0c            98
A10521 -    070315 1300..... 119  75     58     36.2c            98
A10522 -    070315 1150..... 137  73     52     36.5c            99
A10523 -    070315 0945..... 143  85     60     36.4c            97
A10524 -    070308 1100..... 144  87     70     36.0c            98
A10525 -    070301 1645..... 125  62     90 *   36.4c
A10526 -    070301 1505..... 112  69     86 *   36.6c            98
A10527 -    070222 1145..... 115  73     58     36.3c   147      98
A10528 -    070222 1045..... 100  60     56     36.6c   147      98
A10529 -    070222 0930..... 117  63     68     36.2c   147      97
A10530 -    070215 1200..... 106  66     61     37.0c   147      97
A10531 -    070215 1055.....  96  61     64     37.0c   147      94
A10532 -    070215 0930..... 100  64     66     36.7c   147      98
A10533 -    070208 0920..... 143  70     59     36.5c   147      98
A10534 -    070201 1330..... 136  74     66             148      94
A10535 -    070201 1220..... 110  65     62     36.3c   148      96
A10536 -    070201 1000..... 132  80     65     36.9c   148      99
A10537 -    061201 1534..... 123  76     76     97.5    150
A10538 -    061110 1534..... 136  83     73     97.0    150      98
A10539 -    061020 1534..... 140  79     67     99.8    151      97
A10540 -    060929 1452..... 141  78     66     98.3    149
A10541 -    060908 1335..... 139  79     73     98.1    149
A10542 -    060814 1610..... 139  80     59     98.2    151
A10543 -    060722 1440..... 142  74     67     98.1    149
A10544 -    060711.......... 172  87     54     97.5    147
A10545 -    060623.......... 141  87     71     98.0    147
A10546 -    060428.......... 129  73     80     99.4    149
A10547 -    060217.......... 153  81     61     98.6    150
A10548 -    050916.......... 120  80     80     98.5
A10549 -
A10550 -  *  Need vitals taken twice to verify atypical diagnostics.
A10551 -
A10552 -
A10553 -
A10554 -
A106 -

SUBJECTS
Energy Normal Stable Alert Drive Home After Treatment Tired Sleep 2
Cetuximab Chemotherapy Treatments Cancer IBC

AE04 -
AE05 - 1130
AE0601 -  ..
AE0602 - Energy Normal Stable After Treatment Cetuximab Support Drugs
AE0603 -
AE0604 - Follow up ref SDS 34 F54N, ref SDS 30 F54N.
AE0606 -  ..
AE0607 - On 060724 diary side effects for cetuximab chemotherapy treatment on
AE0608 - clinical study drug trial. ref SDS 6 YP4I
AE0610 -  ..
AE0611 - Millie was alert after treatment again today, and not wobbly nor
AE0612 - disoriented.  She was able to drive home without side effects of
AE0613 - treatment.
AE0615 -  ..
AE0616 - After arriving home about 1215, Millie had a light lunch, and then
AE0617 - took a nap from about 1300 until about 1500.  This may relate to side
AE0618 - effects from cetuximab treatments that cause fatigue, reported on
AE0619 - 070116. ref SDS 13 O64M
AE0620 -
AE0621 -
AE0622 -
AE0623 -
AE0624 -
AE0625 -
AE0626 -
AE07 -